Uncategorized
Optovue Showcases Retinal Blood Flow Measurement Capability for Improving Management of Diabetes-Related Vision Loss
FREMONT, Calif. & BARCELONA, Spain--(BUSINESS WIRE)--Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced AngioAnalytics™, a significant expansion of its OCTA technology, at the 33rd congress of the European Society for Cataract and Refractive Surgery (ESCRS) being held in Barcelona, Spain from September 5-9. This new capability will provide clinicians with the ability to quantify the density of blood flow in the
